program death ligand
Recently Published Documents

TOTAL DOCUMENTS

9
(FIVE YEARS 3)

H-INDEX

2
(FIVE YEARS 1)
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Clinical Significance of Program Death Ligand-1 and Indoleamine-2,3-Dioxygenase Expression in Colorectal Carcinoma

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Sean Hacking ◽  
Taisia Vitkovski ◽  
Swachi Jain ◽  
Cao Jin ◽  
Hector Chavarria ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Clinical Significance ◽  
Indoleamine 2,3 Dioxygenase ◽  
Program Death Ligand

scholarly journals The Impact of Patient Characteristics on Tumor Cell Program Death Ligand 1 Expression in Patients With NCSLC

2019 ◽  
Vol 14 (9) ◽  
pp. e211 ◽  
Author(s):  
Zhijie Xu ◽  
Xiang Wang ◽  
Xi Chen ◽  
Zhicheng Gong ◽  
Yuanliang Yan
Keyword(s):  
Tumor Cell ◽  
Patient Characteristics ◽  
The Impact ◽  
Program Death Ligand

Abstract A31: Reprogramming of tumor-associated macrophages by anti-Program Death Ligand 1 (PDL1)

2018 ◽  
Author(s):  
Huizhong Xiong ◽  
Marina Moskalenko ◽  
Ryan Rodriguez ◽  
Stephanie Mittman ◽  
Michelle Yang ◽  
...  
Keyword(s):  
Tumor Associated Macrophages ◽  
Program Death Ligand

scholarly journals Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy

2017 ◽  
Vol 79 (2) ◽  
pp. e12795 ◽  
Author(s):  
Elizabeth Ann L. Enninga ◽  
Susan M. Harrington ◽  
Douglas J. Creedon ◽  
Rodrigo Ruano ◽  
Svetomir N. Markovic ◽  
...  
Keyword(s):  
Immune Checkpoint ◽  
Immune Checkpoint Molecules ◽  
Program Death Ligand ◽  
In Pregnancy
Load More ...
Sign in / Sign up

Export Citation Format

Share Document